These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 15771796)
1. [Expressions of VEGF/VEGFRs and activation of STATs in ovarian carcinoma]. Chen BY; Ye DF; Xie X; Chen HZ; Lü WG Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):33-7. PubMed ID: 15771796 [TBL] [Abstract][Full Text] [Related]
2. VEGF, VEGFRs expressions and activated STATs in ovarian epithelial carcinoma. Chen H; Ye D; Xie X; Chen B; Lu W Gynecol Oncol; 2004 Sep; 94(3):630-5. PubMed ID: 15350351 [TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor (VEGF) and ovarian carcinoma cell supernatant activate signal transducers and activators of transcription (STATs) via VEGF receptor-2 (KDR) in human hemopoietic progenitor cells. Ye F; Chen HZ; Xie X; Ye DF; Lu WG; Ding ZM Gynecol Oncol; 2004 Jul; 94(1):125-33. PubMed ID: 15262130 [TBL] [Abstract][Full Text] [Related]
4. [Serum level and expression of vascular epithelial growth factor in ovarian epithelial carcinoma]. Sun LX; Wu Y; Han HQ; Wang QH Ai Zheng; 2003 Jan; 22(1):58-61. PubMed ID: 12561438 [TBL] [Abstract][Full Text] [Related]
5. [Activation of signal transducers and activators of transcription induced by vascular endothelial growth factor in CD34+ hematopoietic progenitor cells in vitro]. Ye F; Ye DF; Xie X; Chen HZ; Lü WG Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb; 26(1):12-7. PubMed ID: 15052767 [TBL] [Abstract][Full Text] [Related]
6. [Expression and clinical significance of endostatin and vascular endothelial growth factor in ovarian carcinoma]. Shi HR; Song WJ; Chen ZM; Wu QH Ai Zheng; 2005 Sep; 24(9):1127-31. PubMed ID: 16159439 [TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor expression in serous ovarian carcinoma: relationship with high mitotic activity and high FIGO stage. Brustmann H; Naudé S Gynecol Oncol; 2002 Jan; 84(1):47-52. PubMed ID: 11748975 [TBL] [Abstract][Full Text] [Related]
8. Endothelial receptor tyrosine kinases activate the STAT signaling pathway: mutant Tie-2 causing venous malformations signals a distinct STAT activation response. Korpelainen EI; Kärkkäinen M; Gunji Y; Vikkula M; Alitalo K Oncogene; 1999 Jan; 18(1):1-8. PubMed ID: 9926914 [TBL] [Abstract][Full Text] [Related]
9. [Expressions of Cx43 and Skp2 in epithelial ovarian tumor and their clinical significances]. Hu YQ; Liu YJ Ai Zheng; 2005 Jan; 24(1):104-9. PubMed ID: 15642212 [TBL] [Abstract][Full Text] [Related]
10. [Expression and clinical relevance of ARHI, STAT3 and E2F1 in ovarian serous carcinoma]. Zhang J; Li YH; Cui AR; Wang JL; Cheng JX; Wang SJ Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):905-9. PubMed ID: 19173990 [TBL] [Abstract][Full Text] [Related]
11. Localization of vascular endothelial growth factor and its receptors in digestive endocrine tumors: correlation with microvessel density and clinicopathologic features. La Rosa S; Uccella S; Finzi G; Albarello L; Sessa F; Capella C Hum Pathol; 2003 Jan; 34(1):18-27. PubMed ID: 12605362 [TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer. Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150 [TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer. Carrillo de Santa Pau E; Arias FC; Caso Peláez E; Muñoz Molina GM; Sánchez Hernández I; Muguruza Trueba I; Moreno Balsalobre R; Sacristán López S; Gómez Pinillos A; del Val Toledo Lobo M Cancer; 2009 Apr; 115(8):1701-12. PubMed ID: 19197998 [TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor and its soluble receptor in benign and malignant ovarian tumors. Artini PG; Ruggiero M; Monteleone P; Carpi A; Cristello F; Cela V; Genazzani AR Biomed Pharmacother; 2008; 62(6):373-7. PubMed ID: 18037256 [TBL] [Abstract][Full Text] [Related]
16. Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma. Huang Y; Hua K; Zhou X; Jin H; Chen X; Lu X; Yu Y; Zha X; Feng Y Cell Res; 2008 Jul; 18(7):780-91. PubMed ID: 18574502 [TBL] [Abstract][Full Text] [Related]
17. [Expression of hSef and FGF-2 in epithelial ovarian tumor]. Feng QL; Shi HR; Qiao LJ; Zhao J Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):770-4. PubMed ID: 22335910 [TBL] [Abstract][Full Text] [Related]
18. Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer. Sopo M; Anttila M; Hämäläinen K; Kivelä A; Ylä-Herttuala S; Kosma VM; Keski-Nisula L; Sallinen H BMC Cancer; 2019 Jun; 19(1):584. PubMed ID: 31200683 [TBL] [Abstract][Full Text] [Related]
19. Ovarian carcinoma cells and IL-1beta-activated human peritoneal mesothelial cells are possible sources of vascular endothelial growth factor in inflammatory and malignant peritoneal effusions. Stadlmann S; Amberger A; Pollheimer J; Gastl G; Offner FA; Margreiter R; Zeimet AG Gynecol Oncol; 2005 Jun; 97(3):784-9. PubMed ID: 15943987 [TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor expression in serous ovarian carcinoma: relationship with topoisomerase II alpha and prognosis. Brustmann H Gynecol Oncol; 2004 Oct; 95(1):16-22. PubMed ID: 15385105 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]